GMI-1359

N/A

Report date: 2023/11/01 20:08:59
NME

Base Information

Drug NameGMI-1359
Drug Alias NameGMI-1359
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonistsSelectin E inhibitors
TargetsSelectin EC-X-C motif chemokine receptor 4
Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCrescent Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrescent Biopharma Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A